2015年6月 获四川师范大学生物技术专业学士学位

2021年6月 获电子科技大学生物医学工程专业博士学位

2021年7月-2024年5月 四川省人民医院/电子科技大学联合培养，博士后

2024年5月-至今 四川省人民医院，副研究员

担任眼科SCI杂志Visual Neuroscience青年编委

电子科大硕士生导师，在国际主流学术期刊以第一/通讯作者（包括Advance Science，Eye and vision, Nano energy，Science China Life Sciences，Computers In Biology And Medicine，Journal of Nanobiotechnology等）发表学术论文22篇，其中SCI论文21篇，累积影响因子98.631分，北大核心期刊1篇。单篇最高影响因子17.6，单篇文章最高引用次数402次。

作为项目负责人主持国家自然科学基金2项，省科技厅科研项目2项，其他厅局级课题2项；以主研人身份参加国家重点研发计划和国家自然科学面上项目在内的7项课题。以第一作者或通讯作者发表学术论文22篇，其中SCI论文21篇，累积影响因子98.631分，北大核心期刊1篇。申请并获批国家发明专利8项。

近三年代表性论文如下：

1.Genome-Wide Association Analysis Identifies LILRB2 Gene for Pathological Myopia（2024）；第一作者(1)；14.3（中科院1区,Q1）；刊物名：Advance Science

2.A Self-Generated Electricity-Driven Drug Delivery System for Precision Management of Myopia (2023)；第一作者(1)；17.6（中科院1区,Q1）；刊物名：Nano Energy

3.Identification of LRRC46 as a novel candidate gene for high myopia（2024）；第一作者(1)；8.0（中科院1区,Q1）；刊物名：Science China-Life Sciences

4. A Self-Generated Electricity-Driven Sclera reinforcement bionic piezoelectric patch for Management of High Myopia (2025)；第一作者(1)；12.6 (中科院1区,Q1)；刊物名：Journal of Nanobiotechnology

5.Uncovering a novel SERPING1 pathogenic variant: insights into the aggregation of C1-INH in hereditary angioedema. (2024)；第一作者(1)；3.4（中科院2区,Q2）；刊物名：Orphanet J Rare Dis.

6.Association of genetic variants in PDGFRA with high myopia in the Han population of southwestern China (2022)；第一作者(1)；1.810（中科院4区,Q4)；刊物名：Ophthalmic Genet

7.Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment (2023)；第一作者(1)；10.2（中科院1区,Q1）；刊物名：Asian J Pharm Sci

8.Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests  (2022)；第一作者(2)；8.4（中科院2区,Q2）；刊物名：INT J INFECT DIS

9.Identification and validation of a novel six-gene signature based on mucinous adenocarcinoma-related gene molecular typing in colorectal cancer (2024)；通讯作者(1)；2.8（中科院4区,Q2）；刊物名：Discov Oncol

10.Molecular classification and construction of the risk signature for diffuse large B-cell lymphoma based on vitamin B6 metabolism（2025）；通讯作者(1)；2.9（中科院4区,Q2）；刊物名：Discov Oncol

11.A novel PD-1/PD-L1 pathway molecular typing-related signature for predicting prognosis and the tumor microenvironment in breast cancer (2023)；通讯作者(2)；2.2（中科院2区,Q2）；刊物名：Discov Oncol

12.Identifying SLC2A6 as the novel protective factor in breast cancer by TP53-related genes affecting M1 macrophage infiltration（2024）；通讯作者(2)；6.1（中科院2区,Q1）；刊物名：Apotosis

13.Harnessing nano-delivery systems to un-cover the challenges for cervical cancer therapy (2025)；通讯作者(2)；5.2 (2区,Q1)；刊物名：INTERNATIONAL JOURNAL OF PHARMACEUTICS

14.A Novel Pair of Compound Heterozygous Mutation of EYS in a Han Chinese Family with Retinitis Pigmentosa（2023）；通讯作者(2)；1.73（4区,Q4)；刊物名：Genetic testing and molecular biomarkers

15.Nanotechnology Lighting the Way for Gene Therapy in Ophthalmopathy: From Opportunities toward Applications (2023)；通讯作者(2)；4.6（2区,Q2）；刊物名：Molecules

16.Identification of mutation gene prognostic biomarker in multiple myeloma through gene panel exome sequencing and transcriptome analysis in Chinese population (2023)；通讯作者(3)；7.7（1区,Q1）；刊物名：Comput Biol Med

2025年获“四川省医学会年度青年优秀论文”